Potential role of a hybrid intraoperative probe based on OCT and positron detection for ovarian cancer detection and characterization
- PMID: 21750769
- PMCID: PMC3130578
- DOI: 10.1364/BOE.2.001918
Potential role of a hybrid intraoperative probe based on OCT and positron detection for ovarian cancer detection and characterization
Abstract
Ovarian cancer has the lowest survival rate of the gynecologic cancers because it is predominantly diagnosed in the late stages due to the lack of reliable symptoms and efficacious screening techniques. A novel hybrid intraoperative probe has been developed and evaluated for its potential role in detecting and characterizing ovarian tissue. The hybrid intraoperative dual-modality device consists of multiple scintillating fibers and an optical coherence tomography imaging probe for simultaneously mapping the local activities of (18)F-FDG uptake and imaging of local morphological changes of the ovary. Ten patients were recruited to the study and a total of 18 normal, abnormal and malignant ovaries were evaluated ex vivo using this device. Positron count rates of 7.5/8.8-fold higher were found between malignant and abnormal/normal ovaries. OCT imaging of malignant and abnormal ovaries revealed many detailed morphologic features that could be potentially valuable for evaluating local regions with high metabolic activities and detecting early malignant changes in the ovary. These initial results have demonstrated that our novel hybrid imager has great potential for ovarian cancer detection and characterization during minimally invasive endoscopic procedures.
Keywords: (170.3880) Medical and biological imaging; (170.3890) Medical optics instrumentation; (170.4440) ObGyn; (170.4500) Optical Coherence Tomography.
Figures







References
-
- Rebbeck T. R., Lynch H. T., Neuhausen S. L., Narod S. A., Van’t Veer L., Garber J. E., Evans G., Isaacs C., Daly M. B., Matloff E., Olopade O. I., Weber B. L., Prevention and Observation of Surgical End Points Study Group , “Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations,” N. Engl. J. Med. 346(21), 1616–1622 (2002).10.1056/NEJMoa012158 - DOI - PubMed
-
- Kauff N. D., Satagopan J. M., Robson M. E., Scheuer L., Hensley M., Hudis C. A., Ellis N. A., Boyd J., Borgen P. I., Barakat R. R., Norton L., Castiel M., Nafa K., Offit K., “Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation,” N. Engl. J. Med. 346(21), 1609–1615 (2002).10.1056/NEJMoa020119 - DOI - PubMed
-
- Berek J. S., Chalas E., Edelson M., Moore D. H., Burke W. M., Cliby W. A., Berchuck A., Society of Gynecologic Oncologists Clinical Practice Committee , “Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancer,” Obstet. Gynecol. 116(3), 733–743 (2010).10.1097/AOG.0b013e3181ec5fc1 - DOI - PubMed
-
- Pandit-Taskar N., “Oncologic imaging in gynecologic malignancies,” J. Nucl. Med. 46(11), 1842–1850 (2005). - PubMed
LinkOut - more resources
Full Text Sources